Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2025-12-24 @ 9:22 PM
NCT ID:
NCT05083104
Eligibility Criteria:
Inclusion Criteria:
* This study will be conducted on a group of patients who are diagnosed as COVID-19 by PCR, a group of them have mild symptoms and another group admitted in ICU (critically ill patients).
Exclusion Criteria:
* Any clinical condition cause hypercoagulability state such as:
* Pregnancy.
* Recent trauma or surgery.
* Prolonged bed rest or immobility.
* Cancer or its medications, such as tamoxifen, bevacizumab, thalidomide and lenalidomide.
* Hormone replacement therapy.
* Heparin-induced thrombocytopenia (decreased platelets in the blood due to heparin or low molecular weight heparin preparations).
* Previous history of deep vein thrombosis or pulmonary embolism.
* Myeloproliferative disorders such as polycythemia vera or essential thrombocytosis.
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
50 Years
Study:
NCT05083104
Study Brief:
Protocol Section:
NCT05083104